Rucker Michael A.
SEC Form 4 insider trading activity
Rucker Michael A. has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, Rucker Michael A. is listed as Director at Pediatrix Medical Group, Inc. Inside the rolling window, Rucker Michael A. reported no open-market purchases and 1 open-market sale totaling $241K in MD.
Companies traded
Other insiders at MD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$241K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rucker Michael A. made?
Rucker Michael A. has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Rucker Michael A. trade?
Rucker Michael A. has filed SEC Form 4 disclosures for 1 company, including MD.
When was Rucker Michael A.'s most recent SEC Form 4 filing?
Rucker Michael A.'s most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is Rucker Michael A.'s total buy and sell value in the current window?
Inside the rolling retention window, Rucker Michael A. bought $0 and sold $241K based on SEC Form 4 filings.
What was Rucker Michael A.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,478 MD shares on 2025-11-17, worth $241K, per SEC Form 4 filings.